Severe immune dysregulation affects CD4 +CD25 hiFoxP3 + regulatory T cells in HIV-infected patients with low-level CD4 T-Cell repopulation despite suppressive highly active antiretroviral therapy

Journal of Infectious Diseases

Volumn 205, Issue 10, 2012, Pages 1501-1509

  Méndez Lagares, Gema ^a   Pozo Balado, María Mar ^a   Genebat, Miguel ^a   García Pergañeda, Antonio ^a   Leal, Manuel ^a   Pacheco, Yolanda María ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD38 ANTIGEN; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ FOXP3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DYSREGULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD4; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CTLA-4 ANTIGEN; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RNA, VIRAL; SPAIN; T-LYMPHOCYTES, REGULATORY;

EID: 84860372351     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis230     Document Type: Article

References (45)

1. Pacheco YM, Jarrín I, Del Amo J, et al. Risk factors, CD4 long-term evolution and mortality of HIV-infected patients who persistently maintain low CD4 counts, despite virological response to HAART. Curr HIV Res 2009; 7:612-9.
2. Loutfy MR Genebat M Moore D et al. A CD4+ cell count 200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. J Acquir Immune Defic Syndr 2010; 55:451-9
3. Engsig FN, Gerstoft J, Kronborg G, et al. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study. BMC Infect Dis 2010; 10:318.
4. Abrams D, Lévy Y, Losso MH, et al. Interleukin-2 therapy in patients with HIV Infection. N Engl J Med 2009; 361:1548-59.
5. Gazzola L, Tincati C, Bellistri GM, d'Arminio Monforte A, Marchetti G. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps and therapeutic options. Clin Infect Dis 2009; 48:328-37.
6. Aiuti F, Mezzaroma I. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. AIDS Rev 2006; 8:88-97.
7. Molina-Pinelo S, Vallejo A, Díaz L, et al. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation. J Antimicrob Chemother 2009; 64:579-88.
8. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T Cells and Immune Tolerance. Cell 2008; 133:775-87.
9. Shevach EM. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 2009; 30:636-45.
10. Fazekas de St Groth B, Landay AL. Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? AIDS 2008; 22:671-83.
11. Seddiki N, Kelleher AD. Regulatory T cells in HIV infection: who's suppressing what? Curr HIV/AIDS Rep 2008; 5:20-6.
12. Marziali M, De Santis W, Carello R, et al. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART. AIDS 2006; 20:2033-41.
13. Del Pozo-Balado M del M, Leal M, Méndez-Lagares G, Pacheco YM. CD4(f)CD25(r/hi)CD127(lo) phenotype does not accurately identify regulatory T cells in all populations of HIV-infected persons. J Infect Dis 2010; 201:331-5.
14. Montes M, Lewis DE, Sanchez C, et al. Foxp3+ regulatory T cells in antiretroviral-naive HIV patients. AIDS 2006; 20:1669-71.
15. Bi X, Suzuki Y, Gatanaga H, Oka S. High frequency and proliferation of CD4+FOXP3+ Treg in HIV-1-infected patients with low CD4 counts. Eur J Immunol 2009; 39:301-9.
16. Méndez-Lagares G, Leal M, del Pozo-Balado M del M, León JA, Pacheco YM. Is it age or HIV that drives the regulatory T-cells expansion that occurs in older HIV-infected persons? Clin Immunol 2010; 36:157-9.
17. Lim A, Tan D, Price P, et al. Proportions of circulating T cells with a regulatory cell phenotype increasewithHIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007; 21:1525-34.
18. Cao W, Jamieson BD, Hultin LE, Hultin PM, Detels R. Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. AIDS Res Hum Retroviruses 2009; 25:183-91.
19. Seddiki N, Sasson SC, Santner-Nanan B, et al. Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol 2009; 39:391-403.
20. Albuquerque AS, Foxall RB, Soares RS, Victorino RMM, Sousa AE. Increased frequency of CD25+FoxP3+CD4+ T cells in HIV-1 infected patients with low CD4 T cell recovery under ART despite undetectable viremia [abstract MOPEA02]. Presented at: 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention (Sydney. Australia: International Aids Society Sidney, July 22-25), 2007.
21. Kanwar B, Favre D, McCune JM. Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr Opin HIVAIDS 2010; 5:151-7.
22. Almeida ARM, Legrand N, Papiernik M, Freitas AA. Homeostasis of peripheral CD4+ T-cells: IL-2Rα and IL-2 shape a population of regulatory cells that controls CD4+ T-cell numbers. J Immunol 2002; 169:4850-60.
23. Almeida ARM, Zaragoza B, Freitas AA. Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T-cells is indexed to the number of IL-2 producing cells. J Immunol 2006; 177:192-200.
24. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficientmice. Implications for the nonredundant function of IL-2. Immunity 2002; 17:167-78.
25. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AYA. Function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6:1142-51.
26. Bandera A, Ferrario G, Saresella M, et al. CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals. PLoS ONE 2010; 5:e10788.
27. Kinter AL, Hennessey M, Bell A, et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004; 200:331-43.
28. Tsunemi S, Iwasaki T, Imado T, et al. Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients. AIDS 2005; 19:879-86.
29. Baker CA, Clark R, Ventura F, et al. Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection. Clin Exp Immunol 2007; 147:533-9.
30. Sojka DK, Huang YH, Fowell DJ. Mechanisms of regulatory T-cell suppression-a diverse arsenal for a moving target. Immunology 2008; 124:13-22.
31. Tang Q, Bluestone JA. The FoxP3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008; 9:239-44.
32. Szymczak-Workman AL, Workman CJ, Vignali DAA. Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress. J Immunol 2009; 182:5188-92.
33. Baccala R, Theofilopoulus AN. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol 2005; 26:5-8.
34. Bourgeois C, Stockinger B. CD25+CD4+ regulatory T cells and memory T cells prevent lymphopenia-induced proliferation of naive T cells in transient states of lymphopenia. J Immunol 2006; 177:4558-66.
35. Winstead CJ, Reilly CS, Moon JJ, et al. CD4+CD25+FoxP3+ regulatory T cells optimize diversity of the conventional T cell repertoire during reconstitution from lymphopenia. J Immunol 2010; 184:4749-60.
36. Winstead CJ, Fraser JM, Khoruts A. Regulatory CD4+CD25+FoxP3+ T cells selectively inhibit the spontaneous form of lymphopeniainduced proliferation of naive T cells. J Immunol 2008; 180:7305-17.
37. Catalfamo M, Wilhelm C, Tcheung L, et al. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN and IL-7. J Immunol 2011; 186:2106-16.
38. Marchetti G, Gori A, Casabianca A, et al. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART. AIDS 2006; 20:1727-36.
39. Almeida ARM, Ciernik IF, Sallusto F, Lanzavecchia A. CD4+CD25+ Treg regulate the contribution of CD8+ T-cell subsets in repopulation of the lymphopenic environment. Eur J Immunol 2010; 40:3478-88.
40. Erikstrup C, Kronborg G, Lohse N, Ostrowski SR, Gerstoft J, Ullum H. T-cell dysfunction in HIV-1-infected patients with impaired recovery of CD4 cells despite suppression of viral replication. J Acquir Immune Defic Syndr 2010; 53:303-10.
41. Méndez-Lagares G, García-Pergañeda A, Pozo-Balado MD, et al. Differential alterations of the CD4 and CD8 T cell subsets in HIVinfected patients on highly active antiretroviral therapy with low CD4 T cell restoration. J Antimicrob Chemother 2012. doi: 10.1093/jac/dkr594.
42. Marchetti G, Gazzola L, Trabattoni D, et al. Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART. AIDS 2010; 24:1455-60.
43. Min B, Yamane H, Hu-Li J, Paul WE. Spontaneous and homeostatic proliferation of CD4 T-cells are regulated by different mechanisms. J Immunol 2005; 174:6039-44.
44. Sojka DK, Hughson A, Fowell DJ. CTLA-4 is required by CD4+CD25 + Treg to control CD4+ T-cell lymphopenia-induced proliferation. Eur J Immunol 2009; 39:1544-51.
45. Massanella M, Negredo E, Pérez-Álvarez N, et al. CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART. AIDS 2010; 24:959-68.